The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends: Miniperspective
Open accessAbstract
The early effectiveness of combinatorial antiretroviral therapy (cART) in the treatment of HIV infection has been compromised to some extent by rapid development of multidrug-resistant HIV strains, poor bioavailability, and cumulative toxicities, and so there is a need for alternative strategies of antiretroviral drug discovery and additional therapeutic agents with novel action modes or targets. From this perspective, we first review current strategies of antiretroviral drug discovery and optimization, with the aid of selected examples from the recent literature. We highlight the development of phosphate ester-based prodrugs as a means to improve the aqueous solubility of HIV inhibitors, and the introduction of the substrate envelope hypothesis as a new approach for overcoming HIV drug resistance. Finally, we discuss future directions for research, including opportunities for exploitation of novel antiretroviral targets, and the strategy of activation of latent HIV reservoirs as a means to eradicate the virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
Thirumurugan, P., Matosiuk, D., & Jozwiak, K. (2013) · Chemical Reviews · doi:10.1021/cr200409f · Cited by 1,896
Ligand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,152
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F., Strain, M. C., et al. (2012) · Nature · doi:10.1038/nature11286 · Cited by 1,139
Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex
Tan, Q., Zhu, Y., Li, J., Chen, Z., Han, G. W., Kufareva, I., Li, T., Ma, L., Fenalti, G., Li, J., et al. (2013) · Science · doi:10.1126/science.1241475 · Cited by 712
Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry
Whiting, M., Muldoon, J., Lin, Y., Silverman, S. M., Lindstrom, W., Olson, A. J., Kolb, H. C., Finn, M. G., Sharpless, K. B., Elder, J. H., et al. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502161 · Cited by 516
Christ, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479
Fragment-Based Approaches in Drug Discovery and Chemical Biology
Scott, D. E., Coyne, A. G., Hudson, S. A., & Abell, C. (2012) · Biochemistry · doi:10.1021/bi3005126 · Cited by 460
Prolonged and tunable residence time using reversible covalent kinase inhibitors
Bradshaw, J. M., McFarland, J. M., Paavilainen, V. O., Bisconte, A., Tam, D., Phan, V. T., Romanov, S., Finkle, D., Shu, J., Patel, V., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1817 · Cited by 422
Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine
Qin, L., Kufareva, I., Holden, L. G., Wang, C., Zheng, Y., Zhao, C., Fenalti, G., Wu, H., Han, G. W., Cherezov, V., et al. (2015) · Science · doi:10.1126/science.1261064 · Cited by 381
Janssen, P. A. J., Lewi, P. J., Arnold, E., Daeyaert, F., de Jonge, M., Heeres, J., Koymans, L., Vinkers, M., Guillemont, J., Pasquier, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040840e · Cited by 347
Applying thermodynamic profiling in lead finding and optimization
Klebe, G. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4486 · Cited by 295
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Archin, N. M., Sung, J. M., Garrido, C., Soriano-Sarabia, N., & Margolis, D. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3352 · Cited by 275
Ryckmans, T., Edwards, M. P., Horne, V. A., Correia, A. M., Owen, D. R., Thompson, L. R., Tran, I., Tutt, M. F., & Young, T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.062 · Cited by 270
Conformational Restriction: An Effective Tactic in ‘Follow-On’-Based Drug Discovery
Fang, Z., Song, Y., Zhan, P., Zhang, Q., & Liu, X. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.50 · Cited by 268
Self-citationStructural basis of HIV-1 capsid recognition by PF74 and CPSF6
Bhattacharya, A., Alam, S. L., Fricke, T., Zadrozny, K., Sedzicki, J., Taylor, A. B., Demeler, B., Pornillos, O., Ganser-Pornillos, B. K., Diaz-Griffero, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419945112 · Cited by 266
Yang, H.-C., Xing, S., Shan, L., O’Connell, K., Dinoso, J., Shen, A., Zhou, Y., Shrum, C. K., Han, Y., Liu, J. O., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39199 · Cited by 258
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents
Barreca, M. L., Chimirri, A., De Luca, L., Monforte, A.-M., Monforte, P., Rao, A., Zappalà, M., Balzarini, J., De Clercq, E., Pannecouque, C., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00304-3 · Cited by 235
Self-citation8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential
Song, Y., Xu, H., Chen, W., Zhan, P., & Liu, X. (2015) · MedChemComm · doi:10.1039/c4md00284a · Cited by 235
Self-citationMbonye, U., & Karn, J. (2014) · Virology · doi:10.1016/j.virol.2014.02.008 · Cited by 228
Colin, L., & Van Lint, C. (2009) · Retrovirology · doi:10.1186/1742-4690-6-111 · Cited by 222
Reactivation of latent HIV by histone deacetylase inhibitors
Shirakawa, K., Chavez, L., Hakre, S., Calvanese, V., & Verdin, E. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.02.005 · Cited by 217
Mondal, M., & Hirsch, A. K. H. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00493k · Cited by 217
Whiting, M., Tripp, J. C., Lin, Y.-C., Lindstrom, W., Olson, A. J., Elder, J. H., Sharpless, K. B., & Fokin, V. V. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060754+ · Cited by 208
Menéndez-Arias, L. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.01.007 · Cited by 207
Jiang, G., Mendes, E. A., Kaiser, P., Wong, D. P., Tang, Y., Cai, I., Fenton, A., Melcher, G. P., Hildreth, J. E. K., Thompson, G. R., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005066 · Cited by 192
HIV‐1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
Zhan, P., Chen, X., Li, D., Fang, Z., De Clercq, E., & Liu, X. (2013) · Medicinal Research Reviews · doi:10.1002/med.20241 · Cited by 192
Self-citationMulti-objective optimization methods in drug design
Nicolaou, C. A., & Brown, N. (2013) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2013.02.001 · Cited by 192
Emerging strategies to deplete the HIV reservoir
Archin, N. M., & Margolis, D. M. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000026 · Cited by 180
Hierarchical virtual screening approaches in small molecule drug discovery
Kumar, A., & Zhang, K. Y. J. (2014) · Methods · doi:10.1016/j.ymeth.2014.07.007 · Cited by 174
Multi-Parameter Optimization: Identifying High Quality Compounds with a Balance of Properties
D. Segall, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436430 · Cited by 172
DeChristopher, B. A., Loy, B. A., Marsden, M. D., Schrier, A. J., Zack, J. A., & Wender, P. A. (2012) · Nature Chemistry · doi:10.1038/nchem.1395 · Cited by 161
Structures of HIV-1 RT–DNA complexes before and after incorporation of the anti-AIDS drug tenofovir
Tuske, S., Sarafianos, S. G., Clark, A. D., Ding, J., Naeger, L. K., White, K. L., Miller, M. D., Gibbs, C. S., Boyer, P. L., Clark, P., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb760 · Cited by 161
Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence
Celum, C., & Baeten, J. M. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834ef5ef · Cited by 158
Dierynck, I., Wit, M. D., Gustin, E. M., Keuleers, I., Vandersmissen, J., Hallenberger, S., & Hertogs, K. (2007) · Journal of Virology · doi:10.1128/jvi.01184-07 · Cited by 157
Amrane, S., Kerkour, A., Bedrat, A., Vialet, B., Andréola, M., & Mergny, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja501500c · Cited by 157
Clercq, E. D. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.04.011 · Cited by 157
Brik, A., Muldoon, J., Lin, Y., Elder, J. H., Goodsell, D. S., Olson, A. J., Fokin, V. V., Sharpless, K. B., & Wong, C. (2003) · ChemBioChem · doi:10.1002/cbic.200300724 · Cited by 155
Beans, E. J., Fournogerakis, D. N., Gauntlett, C., Heumann, L. V., Kramer, R., Marsden, M. D., Murray, D., Chun, T., Zack, J. A., & Wender, P. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302634110 · Cited by 151
Inhibitors of Histone Deacetylases
Huber, K. D., Doyon, G., Plaks, J. G., Fyne, E., Mellors, J. W., & Sluis‐Cremer, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180224 · Cited by 149
Relationships between Structure and Interaction Kinetics for HIV-1 Protease Inhibitors
Markgren, P.-O., Schaal, W., Hämäläinen, M., Karlén, A., Hallberg, A., Samuelsson, B., & Danielson, U. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0208370 · Cited by 147
Targeting HIV latency: pharmacologic strategies toward eradication
Xing, S., & Siliciano, R. F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.12.008 · Cited by 147
Vernekar, S. K. V., Liu, Z., Nagy, E., Miller, L., Kirby, K. A., Wilson, D. J., Kankanala, J., Sarafianos, S. G., Parniak, M. A., & Wang, Z. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501132s · Cited by 144
Muzammil, S., Armstrong, A. A., Kang, L., Jakalian, A., Bonneau, P. R., Schmelmer, V., Amzel, L. M., & Freire, E. (2007) · Journal of Virology · doi:10.1128/jvi.02706-06 · Cited by 143
Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
Donahue, D. A., & Wainberg, M. A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-11 · Cited by 131
Ligand–receptor interaction platforms and their applications for drug discovery
Ye, F. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.715631 · Cited by 130
Betzi, S., Restouin, A., Opi, S., Arold, S. T., Parrot, I., Guerlesquin, F., Morelli, X., & Collette, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707130104 · Cited by 129
Evolutions in fragment-based drug design: the deconstruction–reconstruction approach
Chen, H., Zhou, X., Wang, A., Zheng, Y., Gao, Y., & Zhou, J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.015 · Cited by 123
Ren, J., Nichols, C. E., Bird, L. E., Fujiwara, T., Sugimoto, H., Stuart, D. I., & STAMMERS, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14316 · Cited by 121
Antibody–drug conjugates – a perfect synergy
Adair, J. R., Howard, P. W., Hartley, J. A., Williams, D. G., & Chester, K. A. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.693473 · Cited by 120
Nalam, M. N. L., Ali, A., Altman, M. D., Reddy, G. S., Chellappan, S., Kairys, V., Özen, A., Cao, H., Gilson, M. K., Tidor, B., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02531-09 · Cited by 120
Suzuki, T., Kasuya, Y., Itoh, Y., Ota, Y., Zhan, P., Asamitsu, K., Nakagawa, H., Okamoto, T., & Miyata, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068669 · Cited by 117
Self-citationAbad‐Zapatero, C., Perišić, O., Wass, J. A. H., Bento, A. P., Overington, J. P., Al‐Lazikani, B., & Johnson, M. E. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.004 · Cited by 116
Altman, M. D., Ali, A., Reddy, G. S., Nalam, M. N. L., Anjum, S. G., Cao, H., Chellappan, S., Kairys, V., Fernandes, M. X., Gilson, M. K., et al. (2008) · Journal of the American Chemical Society · doi:10.1021/ja076558p · Cited by 115
Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
Lin, K. W., & Gallay, P. A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.020 · Cited by 113
Sakane, N., Kwon, H.-S., Pagans, S., Kaehlcke, K., Mizusawa, Y., Kamada, M., Lassen, K. G., Chan, J., Greene, W. C., Schnoelzer, M., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002184 · Cited by 111
Heredia, A., Le, N. M., Gartenhaus, R. B., Sausville, E. A., Medina-Moreno, S., Zapata, J. C., Davis, C. E. L. B., Gallo, R. C., & Redfield, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511144112 · Cited by 106
Pyrazole NNRTIs 4: Selection of UK-453,061 (lersivirine) as a Development Candidate
Mowbray, C. E., Burt, C., Corbau, R., Gayton, S., Hawes, M., Perros, M., Tran, I., Price, D. A., Quinton, F., Selby, M. D., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.080 · Cited by 104
Campos, N., Myburgh, R., Garcel, A., Vautrin, A., Lapasset, L., Nadal, E. S., Mahuteau‐Betzer, F., Najman, R., Fornarelli, P., Tantale, K., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0159-3 · Cited by 102
Design Strategies of Novel NNRTIs to Overcome Drug Resistance
Zhan, P., Liu, X., Li, Z., Pannecouque, C. C., & Clercq, E. D. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789178019 · Cited by 100
Self-citationLuca, L. D., Barreca, M. L., Ferro, S., Christ, F., Iraci, N., Gitto, R., Monforte, A., Debyser, Z., & Chimirri, A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900070 · Cited by 100
Åhgren, C., Backro, K., BELL, F. W., Cantrell, A. S., Clemens, M., Colacino, J. M., Deeter, J. B., Engelhardt, J. A., Högberg, M., & Jaskunas, S. R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1329 · Cited by 99
Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells
Bosque, A., & Planelles, V. (2010) · Methods · doi:10.1016/j.ymeth.2010.10.002 · Cited by 96
Bauman, J. D., Patel, D., Dharia, C., Fromer, M. W., Ahmed, S., Frenkel, Y. V., Vijayan, R., Eck, J. T., Ho, W. C., Das, K., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301271j · Cited by 95
Siliciano, J. D., & Siliciano, R. F. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.026 · Cited by 95
Dawn of non-nucleoside inhibitor-based anti-HIV microbicides
D’Cruz, O. J., & Uckun, F. M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki464 · Cited by 93
Rationally Designed Dual Inhibitors of HIV Reverse Transcriptase and Integrase
Wang, Z., Bennett, E. M., Wilson, D. J., Salomon, C. E., & Vince, R. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070512p · Cited by 92
An Antibody-Recruiting Small Molecule That Targets HIV gp120
Parker, C. G., Domaoal, R. A., Anderson, K. S., & Spiegel, D. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9057647 · Cited by 89
Morningstar, M., Roth, T. F., Farnsworth, D. W., Smith, M. K., Watson, K. M., Robert W. Buckheit, Das, K., Zhang, W., Arnold, E., Julias, J. G., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060103d · Cited by 89
Deng, N., Forli, S., He, P., Perryman, A. L., Wickstrom, L., Vijayan, R., Tiefenbrunn, T. K., Stout, D., Gallicchio, E., Olson, A. J., et al. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506376z · Cited by 84
Matalon, S., Palmer, B. E., Nold, M. F., Furlan, A., Kassu, A., Fossati, G., Mascagni, P., & Dinarello, C. A. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181d3dca3 · Cited by 83
An Unexpected Example of Protein‐Templated Click Chemistry
Suzuki, T., Ota, Y., Kasuya, Y., Mutsuga, M., KAWAMURA, Y., Tsumoto, H., Nakagawa, H., Finn, M. G., & Miyata, N. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002205 · Cited by 82
Cuzzucoli Crucitti, G., Métifiot, M., Pescatori, L., Messore, A., Madia, V. N., Pupo, G., Saccoliti, F., Scipione, L., Tortorella, S., Esposito, F., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501799k · Cited by 81
Clercq, E. D. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-405880-4.00009-3 · Cited by 81
Systems Biology Brings New Dimensions for Structure-Based Drug Design
Pei, J., Yin, N., Ma, X., & Lai, L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504810z · Cited by 81
Kinetic target-guided synthesis
Hu, X., & Manetsch, R. (2010) · Chemical Society Reviews · doi:10.1039/b904092g · Cited by 80
Wightman, F., Lu, H. K., Solomon, A. E., Saleh, S. M., Harman, A. N., Cunningham, A. L., Gray, L. R., Churchill, M. J., Cameron, P. U., Dear, A. E., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000067 · Cited by 80
Design strategies to address kinetics of drug binding and residence time
Cusack, K. P., Wang, Y., Hoemann, M. Z., Marjanovic, J., Heym, R. G., & Vasudevan, A. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.02.027 · Cited by 80
A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
Herschhorn, A., Gu, C., Espy, N., Richard, J., Finzi, A., & Sodroski, J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1623 · Cited by 79
Logsdon, B. C., Vickrey, J. F., Martin, P. D., Proteasa, G., Koepke, J. I., Terlecky, S. R., Wawrzak, Z., Winters, M. A., Merigan, T. C., & Kovari, L. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3123-3132.2004 · Cited by 79
Wielens, J., Headey, S. J., Rhodes, D. I., Mulder, R. J., Dolezal, O., Deadman, J. J., Newman, J. M., Chalmers, D. K., Parker, M. W., Peat, T. S., et al. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112465979 · Cited by 78
Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc
Price, D. A., Armour, D. R., de Groot, M. J., Leishman, D. J., Napier, C. M., Perros, M., Stammen, B., & Wood, A. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.06.012 · Cited by 77
Inhibiting Early-Stage Events in HIV-1 Replication by Small-Molecule Targeting of the HIV-1 Capsid
Kortagere, S., Madani, N., Mankowski, M. K., Schön, A., Zentner, I., Swaminathan, G., Princiotto, A. M., Anthony, K., Oza, A., Sierra, L., et al. (2012) · Journal of Virology · doi:10.1128/jvi.05006-11 · Cited by 77
Serrao, E., Debnath, B., Otake, H., Kuang, Y., Christ, F., Debyser, Z., & Neamati, N. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301632e · Cited by 73
Recent Developments in Computational Prediction of hERG Blockage
Wang, S., Li, Y., Xu, L., et al. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990036 · Cited by 72
Hankins, C. A., & Dybul, M. R. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835b809d · Cited by 71
Tang, J. Y., Maddali, K., Dreis, C. D., Sham, Y. Y., Vince, R., Pommier, Y. G., & Wang, Z. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1002162 · Cited by 70
Nguyen, A. T., Feasley, C. L., Jackson, K. W., Nitz, T. J., Salzwedel, K., Air, G. M., & Sakalian, M. (2011) · Retrovirology · doi:10.1186/1742-4690-8-101 · Cited by 70
Lucera, M. B., Tilton, C. A., Mao, H., Dobrowolski, C. N., Tabler, C. O., Haqqani, A. A., Karn, J., & Tilton, J. C. (2014) · Journal of Virology · doi:10.1128/jvi.00320-14 · Cited by 70
Wrapping up the bad news – HIV assembly and release
Meng, B., & Lever, A. M. (2013) · Retrovirology · doi:10.1186/1742-4690-10-5 · Cited by 68
Wang, J., Kang, X., Kuntz, I. D., & Kollman, P. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049606e · Cited by 67
Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm
Zhan, P., & Liu, X. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788453266 · Cited by 66
Self-citationStructure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity
Curreli, F., Kwon, Y. D., Zhang, H., Scacalossi, D., Belov, D. S., Tikhonov, A. A., Andreev, I. A., Altieri, A., Kurkin, A. V., Kwong, P. D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00709 · Cited by 66
Xue, W., Ban, Y., Liu, H., & Yao, X. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400060j · Cited by 65
Activation of HIV-1 from Latent Infection via Synergy of RUNX1 Inhibitor Ro5-3335 and SAHA
Klase, Z. A., Yedavalli, V. S. R. K., Houzet, L., Perkins, M. R., Maldarelli, F. M., Brenchley, J. M., Strebel, K., Liu, P., & Jeang, K. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003997 · Cited by 65
Corbau, R., Mori, J., Phillips, C., Fishburn, L., Martín, A., Mowbray, C. E., Panton, W., Smith‐Burchnell, C., Thornberry, A., Ringrose, H., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01455-09 · Cited by 62
Swinney, D. C., Beavis, P. A., Chuang, K., Zheng, Y., Lee, I., Gee, P., Deval, J., Rotstein, D. M., Dioszegi, M., Ravendran, P., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12683 · Cited by 61
Combined approaches for HIV cure
Margolis, D., & Hazuda, D. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835ef089 · Cited by 60
3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase
Tang, J. Y., Maddali, K., Métifiot, M., Sham, Y. Y., Vince, R., Pommier, Y. G., & Wang, Z. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1014378 · Cited by 59
Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators
Zhan, P., Itoh, Y., Suzuki, T., & Liu, X. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00229 · Cited by 59
Self-citationNalam, M. N. L., & Schiffer, C. A. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283136cee · Cited by 58
Jones, L. H., Allan, G. A., Barba, O., Burt, C., Corbau, R., Dupont, T., Knöchel, T., Irving, S., Middleton, D. S., Mowbray, C. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801322h · Cited by 57
Novel tactics for designing water-soluble molecules in drug discovery
Walker, M. A. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.960839 · Cited by 56
Peat, T. S., Rhodes, D. I., Vandegraaff, N., Le, G. T., Smith, J. A., Clark, L. J., Jones, E. D., Coates, J. A. V., Thienthong, N., Newman, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040147 · Cited by 55
Computational Strategies in Discovering Novel Non-nucleoside Inhibitors of HIV-1 RT
Barreca, M. L., Rao, A., Luca, L. D., Zappalà, M., Monforte, A., Maga, G., Pannecouque, C. C., Balzarini, J. M., Clercq, E. D., Chimirri, A., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049279a · Cited by 54
Self-citationPescatori, L., Métifiot, M., Chung, S., Masoaka, T., Crucitti, G. C., Messore, A., Pupo, G., Madia, V. N., Saccoliti, F., Scipione, L., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00159 · Cited by 53
Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery
Hennig, M., Ruf, A., & Huber, W. (2011) · Topics in current chemistry · doi:10.1007/128_2011_225 · Cited by 53
Assessment of topical microbicides to prevent HIV-1 transmission: Concepts, testing, lessons learned
Friend, D. R., & Kiser, P. F. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.06.021 · Cited by 53
Maraviroc – A CCR5 Antagonist for the Treatment of HIV-1 Infection
van der Ryst, E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00277 · Cited by 52
Rhodes, D. I., Peat, T. S., Vandegraaff, N., Jeevarajah, D., Le, G. T., Jones, E. D., Smith, J. A., Coates, J. A. V., Winfeld, L. J., Thienthong, N., et al. (2011) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1716 · Cited by 52
Wang, Z., Tang, J. Y., Salomon, C. E., Dreis, C. D., & Vince, R. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.004 · Cited by 51
Recent Advances in the Discovery and Development of Novel HIV-1 NNRTI Platforms: 2006-2008 Update
Zhan, P., Liu, X., & Li, Z. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803231 · Cited by 51
Self-citation1-[2-(Diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazole
Silvestri, R., Artico, M., Massa, S., Marceddu, T., Montis, F. D., & Colla, P. L. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00664-2 · Cited by 50
Parai, M. K., Huggins, D. J., Cao, H., Nalam, M. N. L., Ali, A., Schiffer, C. A., Tidor, B., & Rana, T. M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300238h · Cited by 50
Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
Rasmussen, T. A., Tolstrup, M., Winckelmann, A. A., Østergaard, L. J., & Søgaard, O. S. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23202 · Cited by 50
Kadow, J. F., Ueda, Y., Meanwell, N. A., Connolly, T. P., Wang, T., Chen, C., Yeung, K., Zhu, J., Bender, J. A., Yang, Z. D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201218m · Cited by 49
Maga, G., Radi, M., Gérard, M.-A., Botta, M., & Ennifar, E. (2010) · Viruses · doi:10.3390/v2040880 · Cited by 48
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 – 2010)
Zhan, P., & Liu, X. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.568481 · Cited by 48
Self-citationNew insights into the kinetic target-guided synthesis of protein ligands
Oueis, E., Sabot, C., & Renard, P. (2015) · Chemical Communications · doi:10.1039/c5cc04183j · Cited by 47
Zentner, I., Sierra, L., Fraser, A. K., Maciunas, L. J., Mankowski, M. K., Vinnik, A., Fedichev, P. O., Ptak, R. G., Martín‐García, J., & Cocklin, S. (2013) · ChemMedChem · doi:10.1002/cmdc.201200577 · Cited by 47
Goudreau, N., Lemke, C. T., Faucher, A., Grand‐Maître, C., Goulet, S., Lacoste, J., Rancourt, J., Malenfant, É., Mercier, J.-F., Titolo, S., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400075f · Cited by 46
Marsden, M. D., & Zack, J. A. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.032 · Cited by 45
Micheva‐Viteva, S., Kobayashi, Y., Edelstein, L. C., Pacchia, A. L., Lee, H.-L. R., Graci, J. D., Breslin, J. J., Phelan, B. D., Miller, L. K., Colacino, J. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.195537 · Cited by 44
Cimitan, S., Lindgren, M. T., Bertucci, C., & Danielson, U. H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049343o · Cited by 44
Geitmann, M., Elinder, M., Seeger, C., Brandt, P., de Esch, I. J. P., & Danielson, U. H. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1010513 · Cited by 44
Pery, E., Sheehy, A. M., Nebane, N. M., Brazier, A. J., Misra, V., Rajendran, K. S., Buhrlage, S. J., Mankowski, M. K., Rasmussen, L. A., White, E. L., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.626903 · Cited by 44
Fätkenheuer, G., Staszewski, S., Plettenburg, A., Hackman, F., Layton, G. R., McFadyen, L., Davis, J. D., & Jenkins, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e32832fef5b · Cited by 43
Multi-Objective Optimization Methods in De Novo Drug Design
Nicolaou, C. P., Kannas, C. C., & Loizidou, E. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712802762284 · Cited by 43
Shuman, C. F., Vrang, L., & Danielson, U. H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0499110 · Cited by 42
Hu, G., Li, X., Zhang, X., Li, Y., Ma, L., Yang, L., Liu, G., Li, W., Huang, J. Y., Shen, X., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301226a · Cited by 42
Hartman, T. L., & Buckheit, R. W. (2012) · Molecular Biology International · doi:10.1155/2012/401965 · Cited by 41
Smith, M. B. K., Hose, B. M., Hawkins, A., Lipchock, J. M., Farnsworth, D. W., Rizzo, R. C., Tirado‐Rives, J., Arnold, E., Zhang, W., Hughes, S. H., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020271f · Cited by 41
Ying, H., Zhang, Y., Zhou, X., Qu, X., Wang, P., Liu, S., Lu, D., & Zhu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048832 · Cited by 40
Özen, A., Sherman, W., & Schiffer, C. A. (2013) · Journal of Chemical Theory and Computation · doi:10.1021/ct400603p · Cited by 40
Yeung, K. S., Qiu, Z., Yin, Z., Trehan, A. K., Fang, H., Pearce, B. C., Yang, Z., Zadjura, L. M., D’Arienzo, C. J., Riccardi, K. A., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.117 · Cited by 40
Tiefenbrunn, T. K., Forli, S., Happer, M., González, A., Tsai, Y., Soltis, S. M., Elder, J. H., Olson, A. J., & Stout, C. D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12227 · Cited by 40
In search of small molecules blocking interactions between HIV proteins and intracellularcofactors
Busschots, K., Rijck, J. D., Christ, F., & Debyser, Z. (2008) · Molecular BioSystems · doi:10.1039/b810306b · Cited by 39
Fluorescent HIV-1 Dimerization Initiation Site: Design, Properties, and Use for Ligand Discovery
Tam, V. K., Kwong, D., & Tor, Y. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0675797 · Cited by 38
Dancing with chemical formulae of antivirals: A personal account
Clercq, E. D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.012 · Cited by 38
Tang, J. Y., Maddali, K., Dreis, C. D., Sham, Y. Y., Vince, R., Pommier, Y. G., & Wang, Z. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.069 · Cited by 38
Prabu-Jeyabalan, M., King, N. M., Nalivaika, E. A., Heilek‐Snyder, G., Cammack, N., & Schiffer, C. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1518-1521.2006 · Cited by 38
Mori, M., Nucci, A., Lang, M. C. D., Humbert, N., Boudier, C., Debaene, F., Cianférani, S., Catala, M., Schult-Dietrich, P., Dietrich, U., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500316h · Cited by 38
Pyrazole NNRTIs 1: Design and initial optimisation of a novel template
Mowbray, C. E., Burt, C., Corbau, R., Perros, M., Tran, I., Stupple, P. A., Webster, R., & Wood, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.039 · Cited by 37
Geitmann, M., Unge, T., & Danielson, U. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0504048 · Cited by 37
Small Molecule Regulation of Protein Conformation by Binding in the Flap of HIV Protease
Tiefenbrunn, T. K., Forli, S., Baksh, M. M., Chang, M. W., Happer, M., Lin, Y., Perryman, A. L., Rhee, J., Torbett, B. E., Olson, A. J., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb300611p · Cited by 37
Raheem, I. T., Walji, A. M., Klein, D. J., Sanders, J. M., Powell, D. A., Abeywickrema, P. D., Barbe, G., Bennet, A., Clas, S., Dubost, D. C., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01037 · Cited by 37
Eradication of HIV and Cure of AIDS, Now and How?
Zhang, J., & Crumpacker, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00337 · Cited by 36
Egbertson, M. S., & Egbertson, M. S. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607781212248 · Cited by 35
Recent progress in the research of small molecule HIV-1 RNase H inhibitors
Cao, L., Song, W., Clercq, E., Zhan, P., & Liu, X. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140120121158 · Cited by 34
Self-citationStructure-Guided Discovery of a Novel Aminoglycoside Conjugate Targeting HIV-1 RNA Viral Genome
Ennifar, E., Aslam, M. W., Strasser, P., Hoffmann, G., Dumas, P., & van Delft, F. L. (2013) · ACS Chemical Biology · doi:10.1021/cb400498n · Cited by 34
Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interaction
Dewan, V., Liu, T., Chen, K.-M., Qian, Z., Xiao, Y., Kleiman, L., Mahasenan, K. V., Li, C., Matsuo, H., Pei, D., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb200450w · Cited by 33
Wei, Y., Li, J., Chen, Z., Wang, F., Huang, W., Hong, Z., & Lin, J. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.054 · Cited by 33
Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression
Victoriano, A. F. B., Imai, K., Togami, H., Ueno, T., Asamitsu, K., Suzuki, T., Miyata, N., Ochiai, K., & Okamoto, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.017 · Cited by 32
Pyrazole NNRTIs 3: Optimisation of physicochemical properties
Mowbray, C. E., Corbau, R., Hawes, M., Jones, L. H., Mills, J. E. J., Perros, M., Selby, M. D., Stupple, P. A., Webster, R., & Wood, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.043 · Cited by 31
Vercruysse, T., Basta, B., Dehaen, W., Humbert, N., Balzarini, J. M., Debaene, F., Cianférani, S., Pannecouque, C. C., Mély, Y., & Daelemans, D. (2012) · Retrovirology · doi:10.1186/1742-4690-9-95 · Cited by 31
Self-citationTargeting IκB Proteins for HIV Latency Activation: the Role of Individual IκB and NF-κB Proteins
Fernández, G., Zaikos, T. D., Khan, S. Z., Jacobi, A. M., Behlke, M. A., & Zeichner, S. L. (2013) · Journal of Virology · doi:10.1128/jvi.03251-12 · Cited by 30
Binding Evaluation of Fragment-Based Scaffolds for Probing Allosteric Enzymes
Krimm, I., Lancelin, J., & Praly, J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201439b · Cited by 30
Human Ether-a-Go-Go-Related Gene Channel Blockers and its Structural Analysis for Drug Design
Moorthy, N. S. H. N., Ramos, M. J., & Fernandes, P. A. (2013) · Current Drug Targets · doi:10.2174/138945013804806460 · Cited by 29
Discovery of a small-molecule antiviral targeting the HIV-1 matrix protein
Zentner, I., Sierra, L., Maciunas, L. J., Vinnik, A., Fedichev, P. O., Mankowski, M. K., Ptak, R. G., Martín‐García, J., & Cocklin, S. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.041 · Cited by 29
Discovery of small molecular inhibitors targeting HIV-1 gp120–CD4 interaction drived from BMS-378806
Liu, T., Huang, B., Zhan, P., Clercq, E. D., & Liu, X. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.012 · Cited by 29
Self-citationBustanji, Y. K., Almasri, I. M., Qasem, A., Al‐Bakri, A. G., & Taha, M. O. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00852.x · Cited by 29
Kunze, J., Todoroff, N. K., Schneider, P., Rodrigues, T., Geppert, T., Reisen, F., Schreuder, H., Saas, J., Heßler, G., Baringhaus, K. H., et al. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400712h · Cited by 29
An Overview of Antiretroviral Pre‐Exposure Prophylaxis of HIV Infection
McGowan, I. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12225 · Cited by 28
Wu, C.-H., Wang, C.-J., Chang, C.-P., Cheng, Y.-C., Song, J., Jan, J., Chou, M., Ke, Y., Ma, J., Wong, Y.-C., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501772w · Cited by 28
Mejia, E. J., Loveridge, S. T., Stepan, G. J., Tsai, A., Jones, G. S., Barnes, T. L., White, K. N., Drašković, M., Tenney, K., Tsiang, M., et al. (2014) · Journal of Natural Products · doi:10.1021/np400889x · Cited by 28
Dimova, D., Heikamp, K., Stumpfe, D., & Bajorath, J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400147j · Cited by 28
Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry
Zhao, B., Mankowski, M. K., Snyder, B. A., Ptak, R. G., & LiWang, P. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234799 · Cited by 27
García‐Sosa, A. T., Sild, S., Takkis, K., & Maran, U. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200203h · Cited by 27
Wielens, J., Headey, S. J., Deadman, J. J., Rhodes, D. I., Parker, M. W., Chalmers, D. K., & Scanlon, M. J. (2010) · ChemMedChem · doi:10.1002/cmdc.201000483 · Cited by 27
Reactivation of Latent HIV: Do All Roads go Through P-TEFb?
Budhiraja, S., & Rice, A. P. (2013) · Future Virology · doi:10.2217/fvl.13.52 · Cited by 27
Yu, F., Lu, L., Liu, Q., Yu, X., Wang, L., He, E. W., Zou, P., Du, L., Sanders, R. W., Liu, S., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.12.022 · Cited by 26
Kang, D., Song, Y., Chen, W., Zhan, P., & Liu, X. (2014) · Molecular BioSystems · doi:10.1039/c4mb00147h · Cited by 26
Self-citationNine Crystal Structures Determine the Substrate Envelope of the MDR HIV-1 Protease
Liu, Z., Wang, Y., Brunzelle, J. S., Kovari, I. A., & Kovari, L. C. (2011) · The Protein Journal · doi:10.1007/s10930-011-9316-2 · Cited by 25
La, J., Latham, C. F., Tinetti, R. N., Johnson, A., Tyssen, D. P., Huber, K. D., Sluis‐Cremer, N., Simpson, J. S., Headey, S. J., Chalmers, D. K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423900112 · Cited by 24
Fragment Screening and HIV Therapeutics
Bauman, J. D., Patel, D., & Arnold, E. (2011) · Topics in current chemistry · doi:10.1007/128_2011_232 · Cited by 24
Grammen, C., Ariën, K. K., Muthusamy, V., Joossens, J., der Veken, P. V., Heeres, J., Lewi, P. J., Haenen, S., Augustyns, K., Vanham, G., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.11.005 · Cited by 23
Chu, S., & Gochin, M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.07.026 · Cited by 22
Recent advances in the structure-based rational design of TNKSIs
Zhan, P., Song, Y., Itoh, Y., Suzuki, T., & Liu, X. (2014) · Molecular BioSystems · doi:10.1039/c4mb00385c · Cited by 22
Self-citationDiscovery of MK‐8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption
Walji, A. M., Sánchez, R. I., Clas, S., Nofsinger, R., Ruiz, M. D. L., Li, J., Bennet, A., John, C., Bennett, D. J., Sanders, J. M., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402393 · Cited by 22
Terrazas-Aranda, K., Herrewege, Y. V., Hazuda, D. J., Lewi, P. J., Costi, R., Santo, R. D., Cara, A., & Vanham, G. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01627-07 · Cited by 22
Using Hierarchical Virtual Screening To Combat Drug Resistance of the HIV-1 Protease
Li, N., Ainsworth, R. I., Ding, B., Hou, T., & Wang, W. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00056 · Cited by 21
Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors
Chen, W., Zhan, P., Clercq, E. D., & Liu, X. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798919084 · Cited by 21
Self-citationPreclinical discovery and development of maraviroc for the treatment of HIV
Veljković, N., Vučićević, J., Tassini, S., Glišić, S., Veljković, V., & Radi, M. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1041497 · Cited by 20
Chemically Programmed Antibodies As HIV-1 Attachment Inhibitors
Sato, S., Inokuma, T., Otsubo, N., Burton, D. R., & Barbas, C. F. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400097z · Cited by 20
Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions
Sebastian, N. T., & Collins, K. L. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.956094 · Cited by 20
Winning the Arms Race by Improving Drug Discovery against Mutating Targets
Anderson, A. C. (2011) · ACS Chemical Biology · doi:10.1021/cb200394t · Cited by 19
De Luca, L., Morreale, F., Christ, F., Debyser, Z., Ferro, S., & Gitto, R. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.07.025 · Cited by 17
Blocking Nuclear Import of Pre-Integration Complex: An Emerging Anti-HIV-1 Drug Discovery Paradigm
Zhan, P., Liu, X., & Clercq, E. D. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416335 · Cited by 17
Self-citationBarnable, P., Calenda, G., Bonnaire, T., Menon, R., Levendosky, K., Gettie, A., Blanchard, J., Cooney, M. L., Fernández-Romero, J. A., Zydowsky, T. M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00073-15 · Cited by 15
Haaland, R. E., Evans‐Strickfaden, T., Holder, A. N., Pau, C., McNicholl, J. M., Chaikummao, S., Chonwattana, W., & Hart, C. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00452-12 · Cited by 15
D’Cruz, O. J., Qazi, S., Yiv, S. H., & Uckun, F. M. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.655422 · Cited by 13
Progress Toward Rationally Designed Small-Molecule Peptide and Peptidomimetic CXCR4 Antagonists
Våbenø, J., Haug, B. E., & ROSENKILDE, M. M. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.64 · Cited by 13
Discovery of an HIV integrase inhibitor with an excellent resistance profile
Pryde, D. C., Webster, R., Butler, S. L., Murray, E. J., Whitby, K., Pickford, C., Westby, M., Palmer, M. J., Bull, D. J., Vuong, H. V., et al. (2013) · MedChemComm · doi:10.1039/c3md00014a · Cited by 12
Activity cliff clusters as a source of structure–activity relationship information
Dimova, D., Stumpfe, D., Hu, Y., & Bajorath, J. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1019861 · Cited by 12
Harnessing the therapeutic potential of host antiviral restriction factors that target HIV
Sloan, R. D., & Wainberg, M. A. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.146 · Cited by 12
Zhao, F., Liu, N., Zhan, P., & Liu, X. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.76 · Cited by 12
Self-citationPreparation of Phosphonooxymethyl Prodrugs of HIV-1 Attachment Inhibitors
Leahy, D. K., & Pack, S. K. (2013) · Organic Process Research & Development · doi:10.1021/op400225q · Cited by 10
Towards novel therapeutics for HIV through fragment-based screening and drug design
Tiefenbrunn, T. K., & Stout, C. D. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.09.009 · Cited by 9
Cited by
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
Ghosh, A. K., Osswald, H. L., & Prato, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01697 · Cited by 419
An overview of molecular hybrids in drug discovery
Bérubé, G. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1135125 · Cited by 338
Metadata
- Authors
- Zhan, P., Pannecouque, C., De Clercq, E., & Liu, X.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-11-05
- Volume
- 59
- Issue
- 7
- Pages
- 2849-2878
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2337272231
- Cited by
- 303
- References
- 203
- FWCI
- 20.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.